Overview Dividends

(MMC) Marsh & McLennan Companies - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5717481023

Insurance, Broking, Consulting, Risk, Advisory

MMC EPS (Earnings per Share)

EPS Growth (3Y CAGR): 8.72%
EPS Trend (3Y Correlation): 30.7%

MMC Revenue

Revenue Growth (3Y CAGR): 8.91%
Revenue Trend (3Y Correlation): 74.6%

Description: MMC Marsh & McLennan Companies September 25, 2025

Marsh & McLennan Companies, Inc. (NYSE: MMC) is a global professional-services firm that delivers risk, strategy, and people solutions through two primary operating segments: Risk & Insurance Services and Consulting.

The Risk & Insurance Services segment provides risk-advice, risk-transfer, and risk-control solutions, alongside insurance and reinsurance broking, analytics, and program-management services for corporate clients, public entities, insurers, associations, and high-net-worth individuals.

The Consulting segment offers health, wealth, and career advisory products, as well as specialized management, strategic, economic, and brand consulting for a broad client base.

Key metrics: FY 2023 revenue reached approximately **$21.5 billion**, with an operating margin of **~13 %**, and the segment’s **combined ratio** improved to **92 %**, reflecting stronger underwriting discipline. The company’s growth is being driven by rising corporate demand for cyber-risk mitigation, ESG-linked insurance solutions, and the broader macro trend of increasing capital allocation to risk-management services.

Founded in 1871 and headquartered in New York, MMC operates in the **Insurance Brokers** sub-industry of the GICS classification, positioning it to benefit from the ongoing shift toward integrated risk-consulting and brokerage models.

For a deeper quantitative view, you may find ValueRay’s MMC valuation model worth reviewing.

MMC Stock Overview

Market Cap in USD	91,917m
Sub-Industry	Insurance Brokers
IPO / Inception	1987-12-30

MMC Stock Ratings

Growth Rating	7.58%
Fundamental	77.1%
Dividend Rating	68.6%
Return 12m vs S&P 500	-31.7%
Analyst Rating	3.30 of 5

MMC Dividends

Dividend Yield 12m	1.93%
Yield on Cost 5y	3.52%
Annual Growth 5y	13.47%
Payout Consistency	93.3%
Payout Ratio	30.8%

MMC Growth Ratios

Growth Correlation 3m	-63.3%
Growth Correlation 12m	-58.5%
Growth Correlation 5y	93.8%
CAGR 5y	5.17%
CAGR/Max DD 3y (Calmar Ratio)	0.20
CAGR/Mean DD 3y (Pain Ratio)	1.11
Sharpe Ratio 12m	0.49
Alpha	-34.29
Beta	0.811
Volatility	22.60%
Current Volume	3555k
Average Volume 20d	2751.7k
Stop Loss	172.8 (-3%)
Signal	-0.12

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (4.13b TTM) > 0 and > 6% of Revenue (6% = 1.59b TTM)

FCFTA 0.09 (>2.0%) and ΔFCFTA 1.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 9.83% (prev 11.20%; Δ -1.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 5.34b > Net Income 4.13b (YES >=105%, WARN >=100%)

Net Debt (18.91b) to EBITDA (7.25b) ratio: 2.61 <= 3.0 (WARN <= 3.5)

Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (494.0m) change vs 12m ago -0.40% (target <= -2.0% for YES)

Gross Margin 42.28% (prev 43.06%; Δ -0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 48.70% (prev 48.02%; Δ 0.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 6.66 (EBITDA TTM 7.25b / Interest Expense TTM 956.0m) >= 6 (WARN >= 3)

Altman Z'' 3.11

(A) 0.04 = (Total Current Assets 23.70b - Total Current Liabilities 21.10b) / Total Assets 58.78b

(B) 0.46 = Retained Earnings (Balance) 26.95b / Total Assets 58.78b

(D) 0.51 = Book Value of Equity 22.07b / Total Liabilities 43.42b

Total Rating: 3.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 77.06

1. Piotroski 7.0pt = 2.0

2. FCF Yield 4.61% = 2.31

3. FCF Margin 19.33% = 4.83

4. Debt/Equity 1.41 = 1.58

5. Debt/Ebitda 2.61 = -1.15

6. ROIC - WACC (= 6.40)% = 8.00

7. RoE 28.30% = 2.36

8. Rev. Trend 74.58% = 5.59

9. EPS Trend 30.73% = 1.54

What is the price of MMC shares?

As of November 01, 2025, the stock is trading at USD 178.15 with a total of 3,555,023 shares traded.
Over the past week, the price has changed by -4.50%, over one month by -11.20%, over three months by -10.17% and over the past year by -17.07%.

Is Marsh & McLennan Companies a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Marsh & McLennan Companies (NYSE:MMC) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 77.06 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MMC is around 157.03 USD . This means that MMC is currently overvalued and has a potential downside of -11.86%.

Is MMC a buy, sell or hold?

Marsh & McLennan Companies has received a consensus analysts rating of 3.30. Therefor, it is recommend to hold MMC.

Strong Buy: 4
Buy: 1
Hold: 12
Sell: 3
Strong Sell: 0

What are the forecasts/targets for the MMC price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	218.2	22.5%
Analysts Target Price	218.2	22.5%
ValueRay Target Price	173.5	-2.6%

MMC Fundamental Data Overview October 30, 2025

Market Cap USD = 91.92b (91.92b USD * 1.0 USD.USD)
P/E Trailing = 22.4595
P/E Forward = 19.3424
P/S = 3.4747
P/B = 6.2227
P/EG = 1.9956
Beta = 0.811
Revenue TTM = 26.45b USD
EBIT TTM = 6.37b USD
EBITDA TTM = 7.25b USD
Long Term Debt = 19.43b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.59b USD (from shortTermDebt, last quarter)
Debt = 21.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.91b USD (from netDebt column, last quarter)
Enterprise Value = 110.83b USD (91.92b + Debt 21.43b - CCE 2.51b)
Interest Coverage Ratio = 6.66 (Ebit TTM 6.37b / Interest Expense TTM 956.0m)
FCF Yield = 4.61% (FCF TTM 5.11b / Enterprise Value 110.83b)
FCF Margin = 19.33% (FCF TTM 5.11b / Revenue TTM 26.45b)
Net Margin = 15.60% (Net Income TTM 4.13b / Revenue TTM 26.45b)
Gross Margin = 42.28% ((Revenue TTM 26.45b - Cost of Revenue TTM 15.27b) / Revenue TTM)
Gross Margin QoQ = 38.69% (prev 44.15%)
Tobins Q-Ratio = 1.89 (Enterprise Value 110.83b / Total Assets 58.78b)
Interest Expense / Debt = 1.11% (Interest Expense 237.0m / Debt 21.43b)
Taxrate = 25.05% (253.0m / 1.01b)
NOPAT = 4.78b (EBIT 6.37b * (1 - 25.05%))
Current Ratio = 1.12 (Total Current Assets 23.70b / Total Current Liabilities 21.10b)
Debt / Equity = 1.41 (Debt 21.43b / totalStockholderEquity, last quarter 15.15b)
Debt / EBITDA = 2.61 (Net Debt 18.91b / EBITDA 7.25b)
Debt / FCF = 3.70 (Net Debt 18.91b / FCF TTM 5.11b)
Total Stockholder Equity = 14.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.02% (Net Income 4.13b / Total Assets 58.78b)
RoE = 28.30% (Net Income TTM 4.13b / Total Stockholder Equity 14.58b)
RoCE = 18.73% (EBIT 6.37b / Capital Employed (Equity 14.58b + L.T.Debt 19.43b))
RoIC = 13.86% (NOPAT 4.78b / Invested Capital 34.46b)
WACC = 7.46% (E(91.92b)/V(113.34b) * Re(9.0%) + D(21.43b)/V(113.34b) * Rd(1.11%) * (1-Tc(0.25)))
Discount Rate = 9.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.40%
[DCF Debug] Terminal Value 76.51% ; FCFE base≈4.58b ; Y1≈5.09b ; Y5≈6.66b
Fair Price DCF = 198.3 (DCF Value 97.17b / Shares Outstanding 489.9m; 5y FCF grow 12.84% → 3.0% )
EPS Correlation: 30.73 | EPS CAGR: 8.72% | SUE: 1.40 | # QB: 4
Revenue Correlation: 74.58 | Revenue CAGR: 8.91% | SUE: 0.47 | # QB: 0

Additional Sources for MMC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle